446 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
5 Dec 07
Other Events
12:00am
)
john.elicker@bms.com
jeffrey.macdonald@bms.com
Suketu Desai
Investor Relations
suketu.desai@bms.com
BRISTOL-MYERS SQUIBB COMPANY OUTLINES STRATEGY … (NYSE:BMY) will conduct a comprehensive review of its business and research and development operations, and outline its strategy to improve shareholder value
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
4 Mar 10
Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy
12:00am
Exhibit 99.1
Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy
in Meeting with Investment Community
Well … -Positioned to Deliver in 2010 and On Track to Execute BioPharma Strategy
Provides 2013 Minimum Non-GAAP EPS Guidance
Will Present In-Depth Review
8-K
EX-99
BMY
Bristol-Myers Squibb Co.
8 Jun 01
Bristol-myers Squibb Co 8-K
12:00am
Advances Company's Strategy for Growth,
Focusing on Expanding Medicines Business --
-- Acquisition of Sustiva Enables … ), for
$7.8 billion. The acquisition will further strengthen Bristol-Myers Squibb's
medicines business, which has been the focus of the company's Strategy
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
10 Mar 08
Bristol-myers Squibb Board Elects Jean-marc Huet
12:00am
strategy within the consolidating baby food sector and its resulting acquisition by Groupe Danone. Prior to joining Royal Numico, N.V., he … to allow us to focus on key elements of our next generation BioPharma strategy,” Cornelius added.
- more -
John Celentano, formerly president
8-K
EX-99.2
xj2c6bsftkp55iwk
6 Apr 09
Bristol-myers Squibb Announces Extension of
12:00am
8-K
EX-99.1
kwnc9k
24 Sep 07
Bristol-myers Squibb to Acquire Adnexus Therapeutics
12:00am
CORRESP
ypxezxws
29 Jun 10
Correspondence with SEC
12:00am
425
isq u6wdtxqw5yhp
17 Nov 09
Business combination disclosure
12:00am
8-K
EX-99.1
716meg6qb20ae8z9
12 Oct 01
Acquisition or disposition of assets
12:00am
DEFA14A
yxxspjqdi0um0yhv
22 Apr 24
Additional proxy soliciting materials
8:16am
8-K/A
EX-99.2
33uo n0pk6w
1 Aug 08
Other Events
12:00am
8-K
EX-99.1
8idxc0n 4clbf8im6
7 May 08
Nordic Capital Fund Vii and Avista Capital Partners Agree to Acquire Convatec Business for Approximately $4.1 Billion
12:00am
DEFA14A
bcmz64s7
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
lyl8o5zryb01 wd
10 May 04
Other events
12:00am
8-K
EX-99.1
3yz15wo1oiv
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
8-K
EX-99.1
d655lryjgwtqojfo xrk
20 May 21
Departure of Directors or Certain Officers
4:32pm